Pricing Log in Create free account

MeiraGTx Holdings PLC (MGTX) vs Rigel Pharmaceuticals, Inc. (RIGL)

MeiraGTx Holdings PLC and Rigel Pharmaceuticals, Inc. are both Biotechnology companies. MeiraGTx Holdings PLC and Rigel Pharmaceuticals, Inc. are of similar size ($853.9M and $817.3M). Rigel Pharmaceuticals, Inc. trades at the lower P/E: 2.4× against 11.8×. MeiraGTx Holdings PLC grew revenue faster over the last twelve months: 948.4% against 2.18%. Rigel Pharmaceuticals, Inc. has the higher net margin (106.6% vs 19.9%) and the lower return on invested capital (13.7% vs 66.6%). Across the 21 metrics below, Rigel Pharmaceuticals, Inc. leads on 12 and MeiraGTx Holdings PLC on 9.

Valuation

Metric MGTX RIGL Biotechnology median
P/E 11.83 2.35 10.60
P/S 2.07 2.57 9.40
P/B 3.81 1.66 2.13
Price to free cash flow 81.19 37.96 25.18
EV/EBITDA 3.94 8.30 0.66
EV/Sales 1.96 2.28 9.02
Earnings yield 8.45% 42.49% (32.88%)
Free cash flow yield 1.23% 2.63% (23.13%)

Profitability

Metric MGTX RIGL Biotechnology median
Gross margin 97.95% 89.64% 68.51%
Operating margin 46.30% 26.28% 0.00%
Net margin 19.87% 106.59% 0.00%
Free cash flow margin 2.55% 31.20% 0.00%
Return on equity 72.22% 109.18% (51.96%)
Return on assets 26.54% 80.16% (46.06%)
Return on invested capital 66.60% 13.69% 0.00%

Growth

Metric MGTX RIGL Biotechnology median
Revenue growth (TTM) 948.35% 2.18% 6.76%
EPS growth (last fiscal year) 33.02% 1,867.68% 29.88%
Revenue growth, 5-year CAGR 39.22% 22.06% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MGTX RIGL Biotechnology median
Debt to equity 0.46 0.00 0.00
Current ratio 3.76 2.39 4.97
Net debt to EBITDA 0.18 (1.05) 1.01

Dividend

Metric MGTX RIGL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MGTX RIGL Biotechnology median
Market cap 817.32m 853.86m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack